Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$30.59 USD
-0.16 (-0.52%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $30.59 0.00 (0.00%) 5:04 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.31 | -2.03% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.28 per share, beating the Zacks Consensus Estimate of $-0.33 per share. This reflects a positive earnings surprise of 15.15%. Look out for APLS's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year increase of 73.5%.
Earnings History
Price & Consensus
Zacks News for APLS
Why Is SpringWorks Therapeutics (SWTX) Up 11.7% Since Last Earnings Report?
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services